Navigation Links
Micromet to Present at the Piper Jaffray 20th Annual Health Care Conference
Date:11/26/2008

BETHESDA, Md., Nov. 26 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that its President and Chief Executive Officer, Dr. Christian Itin, will present at the Piper Jaffray 20th Annual Health Care Conference at the New York Palace Hotel on Wednesday, December 3, 2008. A simultaneous webcast of the presentation will be available on the company's website at www.micromet-inc.com.


    Forum:      The Piper Jaffray 20th Annual Health Care Conference
    Date:       Wednesday, December 3, 2008
    Time:       1:30 pm, Eastern Time
    Place:      The New York Palace
                455 Madison Avenue
                New York, NY 10022
    Webcast:    www.micromet-inc.com

In addition, Dr. Itin will participate in a panel discussion titled "Novel Antibody Technologies," which will be held at the conference on the same day from 12:00 noon until 1:00 pm, eastern time.

About Micromet, Inc.

Micromet, Inc. (www.micromet-inc.com) is a biopharmaceutical company with offices in Bethesda, MD and Munich, Germany. The Company is focused on developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. The Company's novel antibody technology is based on its proprietary BiTE antibody platform, representing a new class of antibodies that specifically activate T cells from the patient's own immune system to eliminate cancer cells or other disease related cells. Four of the Company's antibodies are currently in clinical trials, with the remainder of its product pipeline
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia
2. Micromets BiTE(R) Antibodies Reveal Unique Mode of Action
3. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
4. Micromet, Inc. Reports First Quarter 2008 Financial Results
5. Micromet, Inc. Reports Second Quarter 2008 Financial Results
6. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
7. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
8. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
9. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
11. AtriCure to Present at Roth Capital Partners 2007 New York Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ion,s advanced device control capabilities will en...k and quickly enhance their data security policy e... AZ (PRWEB) Nov. 9, 2009 -- Lumension, a global le...nounced the general availability of Lumension®...) to enable users to protect corporate data while...
(Date:11/9/2009)...and Hartwig are collaborating to provide Davis App... CNC machines. The equipment will be used to prov...Okuma open-architecture THINC control. Grand Open... Charlotte, NC (PRWEB) November 9, 2009 -- Okuma ...d distributor Hartwig, Inc. will provide machine t...
(Date:11/9/2009)... percent of seniors have changed Medicare plans, 1...rvice and improved coverage among biggest drivers ...rs , , Belleville, Il (Vo...eniors have changed their Medicare plan since beco...port they are likely to or are considering switchi...
(Date:11/9/2009)...re/ -- Davis Bregman , a pain management physic...s of Manhattan in New York City. Patients will be...ffice at 212-918-1629 or sending an email from d...to see the doctor in the less stressful home setti...eing most patients. The service will be fee for s...
(Date:11/9/2009)...involving 2,453 women ages 18 to 68 found that lub...partner contributed to higher ratings of pleasurab...ve long been recommended to women to improve the c...k of vaginal tearing, yet strikingly little availa... or associated vaginal symptoms. , The study, c...
Breaking Medicine News(10 mins):Health News:Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance 2Health News:Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance 3Health News:Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance 4Health News:Okuma America Corporation & Hartwig, Inc. to Provide Machines to Davis Applied Technology College for Machine Tool Technology Program 2Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 2Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 3Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 4Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 5Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 3
...eiterates Call for Action and Asks Patients to Sha...ttributable,to Nancy Nielsen, M.D., American Medic...es to face a crisis of about 46 million,uninsured,...lem does not discriminate, it affects each and eve...
...ent Day Working on the Job with Homecare Worker Be...r Pauline Beck will address the Democratic Convent...ending the day with Barack Obama as he,"walked a d...xperience I,ll,never forget and tonight I get to s...
...-Sponsored Health Coverage Continues to Drop Even ...llion Uninsured Number for 2007 Exceeds the Combin...lumbia, DENVER, Aug. 26 The Census Bureau,s annu...age for America,s workers., While the uninsured n...
...BURGHA new study from researchers at the Universit...ds light on why smokers, intentions to quit "cold .... , If a smoker isn,t yearning for a cigarette w... in the September issue of Psychological Science ...
...could aid drug manufacturers in development of new... News) -- New findings that antipsychotic drugs ma...o changes in how the drugs are developed and presc...D2 receptor inside cells. The Duke researchers fou...
...ERDALE, Fla., Aug. 26 WaterPure,International, In...ard:,WPUR) announced today that it has executed an...license agreement with Everest Water, Ltd. revisin... The revised terms now call for gradually escalati...
Other Medicine News:Health News:High Number of Uninsured Hits Home For Many Americans 2Health News:SEIU Member Pauline Beck to Address Convention Tonight 2Health News:Number of Uninsured Decreased in 2007 But Census Report Shows Growing Health Coverage Problems 2Health News:Trouble quitting?: A new Pitt-Carnegie Mellon smoking study may reveal why 2Health News:Scientists ID Pathway That Makes Antipsychotic Drugs Work 2Health News:WaterPure International, Inc. and Everest Water Ltd. Revise Payment Terms of Patent License to Produce Water From Air 2
(Date:11/7/2009)... 7 Patients reported C1-esterase i...apy in treating acute swelling attacks at any body...rder, according to data presented today at the 200...logy (ACAAI) Annual Meeting. The results come from...arallel with the ongoing, prospective, open label ...
(Date:11/6/2009)...RNewswire-FirstCall/ -- Oxygen Biotherapeutics, In... a previously approved reverse split of its common... Monday, Nov. 9, 2009 on a 1-for-15 split-adjusted...rade under the new symbol OXBT. The stock also wil...plit becomes effective. ,, "This reverse split ...
(Date:11/6/2009)... 6 DUSA Pharmaceuticals,...pany that is developing and marketing Levulan(...focused on patients with common skin conditions, a...tive Officer, will present a corporate overview at...Tuesday, November 10, 2009 at 10:00 a.m. ET at the...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Wolf reintroduction proposed in Scottish Highland test case 9286 1Wolf reintroduction proposed in Scottish Highland test case 9286 2Wolf reintroduction proposed in Scottish Highland test case 9286 3Sysmex America Debuts High end Sample Management System During AACC 52129 1Sysmex America Debuts High end Sample Management System During AACC 52129 2Sysmex America Debuts High end Sample Management System During AACC 52129 3Understanding Managed Markets 3A Effective Market Research Structures 26 Activities to Maximize Payer Access 26 Insights 13093 1Understanding Managed Markets 3A Effective Market Research Structures 26 Activities to Maximize Payer Access 26 Insights 13093 2
...efficient capture of lifestyle, demographics and c...t-in time saving and error checking devices such a... user definable pop up tables ensuring consistent ...n the pop up tables means that the user simply has...
RLISYS
K-4500
SF-3000
Medicine Products: